RT Journal Article
SR Electronic
T1 Bridging Language Gaps in Neurology Patient Education Through Large Language Models: a Comparative Analysis of ChatGPT, Gemini, and Claude
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.23.24314229
DO 10.1101/2024.09.23.24314229
A1 Haq, Mahdi
A1 Ur Rehman, Muhammad Mushhood
A1 Derhab, Mohamed
A1 Saeed, Reeda
A1 Kalia, Junaid
YR 2024
UL http://medrxiv.org/content/early/2024/09/24/2024.09.23.24314229.abstract
AB This study evaluates the capability to translate neurology patient education material using three Large Language Models (LLMs) - ChatGPT-4 Omni, Gemini 1.5 Pro, and Claude 3.5 Sonnet. Five neurological conditions (Bell’s palsy, multiple sclerosis, stroke, migraine, and epilepsy) were translated from English into Spanish, Urdu, and Arabic. The translations were assessed by physicians using four metrics: accuracy, clarity, comprehensiveness, and readability at a 6th grade level. Results showed that Claude outperformed both ChatGPT and Gemini overall, particularly excelling in Spanish and Urdu translations, while Gemini led in Arabic. All LLMs demonstrated superior performance in Spanish compared to Urdu and Arabic. This study highlights the potential of LLMs in enhancing patient education across languages, while also identifying areas for improvement in translation accuracy and readability.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.